By [Your Name/Editorial Staff]
October 13, 2025
The moment a physician utters the words "Stage 4 breast cancer," the world shifts on its axis. For Miriam Sabo, that moment arrived at age 42, shattering the illusion of a linear, predictable life. Sabo, like approximately 6% of all breast cancer patients, was diagnosed with de novo metastatic breast cancer (MBC)—meaning the disease had already metastasized to distant organs, in her case, the liver, at the time of her initial diagnosis.
Today, more than six years post-diagnosis, Sabo’s story serves as a profound testament to the resilience of the human spirit, the evolving landscape of cancer treatment, and the vital role of psychosocial support systems. Her journey is not one of "fighting to win" in the traditional, temporary sense, but one of navigating the complexities of chronic, non-curative care with grace, faith, and intentionality.
The Reality of De Novo Metastasis: Main Facts
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells spread from the original tumor in the breast to other parts of the body, such as the bones, liver, lungs, or brain. De novo MBC is a specific classification where the cancer is found to be metastatic at the very first diagnosis.
Unlike early-stage breast cancer, where the primary objective is often eradication through surgery, radiation, and curative-intent chemotherapy, the medical management of MBC is fundamentally different. It is a chronic condition that requires continuous treatment to manage the growth of the cancer and maintain quality of life.
Sabo’s perspective on terminology is telling: she rejects the term "terminal" in favor of "non-curative." This distinction is not merely linguistic; it is a paradigm shift. It acknowledges the reality of the disease while refusing to succumb to the fatalism often associated with the term "terminal." As she notes, the prevailing narrative of "beating" cancer—often characterized by aggressive imagery of boxing gloves and battle cries—felt alien to her. Instead, she had to reconcile herself to a lifetime of treatment, choosing to focus on the quality of her "forever," however long that might be.
A Chronological Journey: Six Years and Counting
Sabo’s journey did not begin with her diagnosis; it began years earlier with a proactive inquiry into genetic health. Having previously reached out to the organization Sharsheret regarding BRCA testing—for which she tested negative—she already possessed a point of contact for when her world would eventually turn upside down.
The Initial Shock (Year 0)
When the diagnosis arrived, the psychological toll was immediate. The initial weeks were a blur of processing, questioning, and navigating the healthcare system. Sabo emphasizes that during this time, the "cancer team" she assembled was just as important as her oncologists. She leaned heavily on Sharsheret, specifically finding a lifeline in a dedicated social worker who served as a vital sounding board for her unfiltered thoughts and anxieties.
Finding Purpose in Advocacy (Years 1–3)
As she stabilized, the trajectory of her journey shifted from survival to service. Encouraged by the organization’s leadership, including the head of their Embrace program, Sabo transitioned into the role of a peer supporter. This pivot proved transformative; by supporting other women navigating the same isolating diagnosis, she found a sense of agency that the cancer cells had attempted to strip away.
Living in the Present (Years 4–6.5)
Today, six and a half years after the initial shock, Sabo describes her life as one of profound gratitude. She has reached milestones that many with her prognosis are told to temper their expectations for: watching her four children grow, celebrating graduations, and witnessing the marriages of two of her children. Most importantly, she highlights the "day-in and day-out" moments—the mundane, precious fragments of life that compose the true essence of existence.
Supporting Data and the "Statistic" Trap
In the oncology community, there is a recurring warning: "Don’t Google the statistics." Sabo echoes this sentiment, understanding that statistics are aggregate data points, not prophecies for individuals.
The survival rate for MBC has been steadily improving due to advancements in targeted therapies, immunotherapy, and hormone-based treatments. However, the emotional burden remains significant. Research indicates that patients with metastatic disease suffer from unique psychosocial stressors, including "scanxiety"—the intense anticipation and fear surrounding periodic imaging—and the challenge of balancing chronic treatment side effects with daily functional needs.
Sabo’s motto, "I am not milk; there is no expiration date stamped on me," is a pushback against the reductive nature of medical data. While she is acutely aware that she is living beyond the statistical averages, she refuses to let those numbers dictate the boundaries of her hope.
Institutional Support: The Role of Sharsheret
Organizations like Sharsheret (Hebrew for "chain") play a critical role in the support architecture for Jewish women and their families facing breast and ovarian cancer. Their Embrace program is specifically tailored for those living with advanced breast cancer, providing a network that addresses the long-term, non-curative reality of the disease.
The importance of this support cannot be overstated. Clinical studies show that patients who engage with psychosocial support programs report better adherence to treatment regimens, lower levels of depression, and improved overall quality of life. For Sabo, the support was not just clinical; it was existential. It allowed her to redefine her identity from "patient" to "mother, advocate, and woman living with purpose."
Implications: A New Way to Live
The implications of stories like Miriam Sabo’s are far-reaching. They challenge the healthcare system to provide more than just pharmacological intervention. They call for:
- Patient-Centered Communication: Physicians must move beyond providing cold, statistical data and engage in conversations that prioritize the patient’s definition of "quality of life."
- Psychosocial Integration: Support systems like peer-to-peer mentoring should be considered a standard component of care for metastatic patients, not an optional extra.
- Reframing the Narrative: The cultural obsession with "beating" cancer is often detrimental to those for whom "beating" the disease is not an option. A shift toward "living with" cancer acknowledges the reality of the patient’s life without diminishing their courage.
A Faith-Based Foundation
For Sabo, the anchor in her journey has been her faith. She notes that her belief in a higher plan—one that remains "for good," even amidst suffering—provides a framework for acceptance. This faith does not erase the difficulty of the diagnosis, but it provides the resilience necessary to navigate the "hardest of moments."
Conclusion
Miriam Sabo’s story is a profound reminder that life is not defined by the expiration dates others might place upon it. By choosing to embrace the present, seeking out community support, and rejecting the labels that threaten to define her, she has carved out a life of deep meaning.
Her message is clear: whether or not you are "beating" the disease, you are undeniably living. And in that living, there is space for growth, connection, and joy. As she continues her journey, she remains a beacon for others, proving that even when the path is uncertain, the way it is walked makes all the difference.
For those currently in the thick of a new diagnosis, Sabo’s advice remains consistent: build your team, find your people, and never let a statistic tell you how much life you have left to live.
About the Author
